Global Ganja Report

2018 saw historic strides toward the liberation of the cannabis plant, from the proverbial four corners of the Earth—North America to the Antipodes. Canadian legalization garnered big headlines, but there were significant breaks with the global prohibition regime in several other countries—including some seemingly unlikely candidates, in regions where the anti-cannabis stigma is deeply entrenched.

When the United Kingdom announced the historic step of rescheduling cannabis and allowing physicians to prescribe it two months ago, there was concern from patients and advocates as to whether actual herbaceous flower would be allowed, or only extracts. Now the first patient is approved to receive cannabis under the program, and it is indeed to be dried flower. The bad news: with the National Health Service barred by bureaucratic hurdles from providing it, patients are at the mercy of the market—and the price is prohibitive. 

The British government has finally capitulated to pressure from patients, activists and even regional authorities, and officially pledged to make medical cannabis products available on prescription this year. But it remains to be seen which products will win approval—and actual herbaceous cannabis is unlikely to make the cut.

In another sign of turning tides, a prestigious British think-tank once beloved of Margaret Thatcher has called on the government to legalize cannabis. The breakthrough report finds that a legal cannabis industry could raise £1 billion per year in tax revenues for the United Kingdom, while undercutting the black market.

The horrific case of an elderly Jewish woman in Paris killed in a clear anti-Semitic attack is being painted as an incidence of "cannabis delirium." Despite all the progress since the days of Reefer Madness in the 1930s, cannabis is still  blamed for violent crime by law enforcement and media alike. Such irrational ugliness has also been repeatedly seen in the cases that have inspired Black Lives Matter on our side of the Atlantic.

A British Columbia firm which is one of Canada's leading licensed producers of medical marijuana has entered a partnership with the national subsidiary of Sandoz, a global leader in the pharmaceutical industry. The deal is being hailed as a milestone that signals the arrival of cannabis in the corporate economy.

A United Nations study brings back the surprise finding that the world's biggest producer of legal cannabis is Great Britain. The answer to this seeming anomaly lies in one UK-based multinational corporation with industrial-scale grow operations for production of pharmaceuticals.

The Dutch police association has released a lurid report asserting that the Netherlands is becoming a "narco-state," with authorities unable to keep ahead of criminal enterprises bringing illegal drugs into the country. There have in fact been some recent cases of grisly narco-violence in the Netherlands, of the kind more commonly associated with Mexico or Colombia. The report will provide further propaganda for opponents of the Dutch gedoogbeleid (tolerance policy) toward the sale of cannabis—but a link between that and the recent violence is dubious.